Search alternatives:
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
50 ppm » 5 ppm (Expand Search)
100 we » 100 de (Expand Search)
50 ng » 50 mg (Expand Search), 10 ng (Expand Search), 5 ng (Expand Search)
Showing 1 - 20 results of 4,392 for search '(( 50 ppm decrease ) OR ((( 50 ng decrease ) OR ( 100 we decrease ))))', query time: 0.60s Refine Results
  1. 1
    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input.

    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. by Lizhi Yu (12476136)

    Published 2022
    Save to List
    Saved in:
  2. 2
    IC<sub>50</sub>s data of antimalarials against controls.

    IC<sub>50</sub>s data of antimalarials against controls. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Drugs IC<sub>50</sub>s data during the study period.

    Drugs IC<sub>50</sub>s data during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    SNPs IC<sub>50</sub>s data at codon 876 during the study period.

    SNPs IC<sub>50</sub>s data at codon 876 during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested.

    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 6
    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs.

    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

    Published 2024
    Save to List
    Saved in:
  7. 7
    For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages.

    For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. by Bert Baumgaertner (3595814)

    Published 2020
    Save to List
    Saved in:
  8. 8
    ROC curve and P-R curve (attack traffic proportion = 50%).

    ROC curve and P-R curve (attack traffic proportion = 50%). by Longyan Ran (18452261)

    Published 2024
    Save to List
    Saved in:
  9. 9
    Number of samples per site during the study period.

    Number of samples per site during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 10
    Performance of selected antimalarials against field isolates during the study period.

    Performance of selected antimalarials against field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    <i>Pfmrp1</i> gene SNPs data during the study period.

    <i>Pfmrp1</i> gene SNPs data during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 12
    Performance of selected drugs against field isolates during the study period.

    Performance of selected drugs against field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 13
    Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.

    Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 14
    <i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials.

    <i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 15
    <i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period.

    <i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 16
    Primers used for analysis of four SNPs in one gene.

    Primers used for analysis of four SNPs in one gene. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 17
    Mitigation (decreasing) scenario.

    Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

    Published 2025
    Save to List
    Saved in:
  18. 18
    Ammonia (NH<sub>3</sub>) measurement (ppm) on the last day of a cage-change cycle in the front, middle and rear of the cage, for each site and sex.

    Ammonia (NH<sub>3</sub>) measurement (ppm) on the last day of a cage-change cycle in the front, middle and rear of the cage, for each site and sex. by B. Ulfhake (6293984)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 19
    ngLVA degradation kinetics.

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”
    Save to List
    Saved in:
  20. 20
    PPM1A is critical for proliferation of intestinal organoids.

    PPM1A is critical for proliferation of intestinal organoids. by Ruyuan Zhou (10197187)

    Published 2021
    “…A dramatic lower number of de novo crypts (D, top panel) and the decreased size of organoids (D, bottom panel) were seen in organoids from PPM1A KO mice, with roughly 50 intestine organoids each group examined. …”
    Save to List
    Saved in:

Search Tools: